Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyridazines as EGFR and/or KRAS inhibitors

Substituted pyridazines as EGFR and/or KRAS inhibitors

US Patent 9562019 · Granted Feb 7, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Drug-conjugates, conjugation methods, and uses thereof2024
CDC7 kinase inhibitors and uses thereof2024
Drug-conjugates with a targeting molecule and two different drugs2024
CDC7 kinase inhibitors and uses thereof2023
Cdc7 kinase inhibitors and uses thereof2021
Drug-conjugates, conjugation methods, and uses thereof2021
Drug-conjugates with a targeting molecule and two different drugs2020
CDC7 kinase inhibitors and uses thereof2018
Drug-conjugates, conjugation methods, and uses thereof2018
CDC7 kinase inhibitors and uses thereof2017
CDC7 kinase inhibitors and uses thereof2016
CDC7 kinase inhibitors and uses thereof2015